After being fired, I became the light of medicine

Chapter 121 Global Nephrology Summit (Subscription Request)

ten minutes later,

Zhang Yang took out 2000 yuan from his bag and put it on the coffee table. He then told Jiang Yong that if he still wanted to come to work after finishing his work, he could report to work at any time.

There was only so much he could do.

Of course, he could give Jiang Yong some money to make Jiang Yong's life a little easier.

But can he guarantee that Zhang Yong, who is on dialysis, will still be alive in ten or fifteen years?
Can he guarantee that Jiang Yong’s wife will never leave him?

and.

There are millions of patients with uremia and more than one million dialysis patients across the country. Can he help them all?
impossible.

He couldn't help, but what he could really do was to use Qingshan Pharmaceutical to find ways to truly improve the quality of life of these dialysis patients so that they could have a certain ability to earn money to support their families.

For example, the "Kidney Toxin Clearing Dialysis Replacement Needle" obtained from the simulator.

"Come on, Zhang Yang."

He sighed and returned to Qingshan Pharmaceutical an hour later.

Perhaps influenced by Jiang Yong's incident, Zhang Yang locked the door and entered the simulator after returning to the office. He wanted to see if the next node of the simulator was still about kidney disease.

But after entering the simulator, the next new node did not appear, so I had to exit again.

In desperation, he went to the International Society of Nephrology (ISN), a world-renowned kidney academic forum, to see if there had been any recent advances in dialysis technology.

Actually,
Because of the research system award for "Kidney Toxin Clearing Dialysis Replacement Needle" some time ago, he has gained more and deeper understanding of dialysis.

Hemodialysis was first introduced in the country about 25 years ago.

Before it appeared, the only way to treat uremia was kidney transplantation, commonly known as "kidney transplant", but kidney transplantation is expensive, and where can we find so many kidneys?
Therefore, the emergence of dialysis has brought hope of life to countless patients with uremia in China and prolonged the lives of countless people.

But hemodialysis is not without side effects, and it can even be said that the side effects are very severe.

In daily life, normal humans take in food and energy, which the body metabolizes and excretes.

For example, after eating and drinking water at noon, the metabolites and toxins produced by these foods will be excreted from the body in urine about two hours later.

In this way, there are always only a small amount of toxins in the human body.

But dialysis patients are different!

Once patients with uremia undergo dialysis, they will soon have no urine at all, and they will begin to rely entirely on hemodialysis to eliminate toxins.

Normally, dialysis is performed three times a week, with two to three days between each dialysis. That is to say, after each dialysis, all toxins and metabolic substances produced by the body will accumulate in the body for a full two to three days until the next dialysis is completed!

This situation may be fine for one or two years.
But for ten or fifteen years, a large amount of toxins will accumulate in the body almost every day and cannot be excreted. If this continues for a long time, it will inevitably cause irreversible effects on organs such as the heart, liver, and blood vessels.

Especially the heart.

During the two-day period, the human body needs to drink water. If the water cannot be excreted, it will inevitably increase the workload on the heart. This is why most dialysis patients will have heart problems after five years.

This is also the reason why the vast majority of dialysis patients eventually die from heart failure or myocardial infarction.

In addition,

Since dialysis patients undergo hemodialysis once a day, all dialysis patients will have a "fistula".

Simply put, the tube used to guide blood input and output is buried in the body for a long time, so there is no need to re-insert the needle every time dialysis is performed. It is similar to an "indwelling needle."

But this method of having tubes buried in the body 365 days a year is prone to infection, and secondly...

And most importantly, it can easily cause vascular sclerosis.

In fact, these are not so serious. The biggest risk of hemodialysis is sudden hypotension.

Hemodialysis will extract blood from the body. This method cannot avoid the reduction of blood volume in the body and the lowering of blood pressure. If the patient also has other complications at this time, it is easy for him to die directly from hemodialysis.

This is not an exaggeration. Every year, countless dialysis patients die in the dialysis room and cannot be rescued.

These are also the main reasons why the median survival period of uremia dialysis in China is currently 13.7 years.

As he was thinking about it, Zhang Yang withdrew from the "International Society of Nephrology Forum" and gradually he sorted out his thoughts.

Next, he will develop and market the "Kidney Toxin Clearing Dialysis Replacement Needle" provided by the system as soon as possible to provide a better quality of life for countless dialysis patients.

At the same time, we will also see whether we can use the existing R&D team to develop a drug that can treat or maintain the progression of early and mid-stage chronic nephritis based on the "Kidney Toxin Clearing Dialysis Replacement Needle" and truly reduce the number of patients with uremia.

After making up his mind, Zhang Yang began to focus his main energy on these two things.

But a few days later, when he was actively preparing for the kidney disease research and development team of Qingshan Pharmaceutical, Ren Xiaomin suddenly put a resume in front of him.

"Zhang Yang, I have read the resume in detail, and I have also interviewed with Wei Tian."

"To be precise, it wasn't an interview, but we talked for a while. His ability, ideas, and insights are beyond reproach. He can be considered a big shot in the industry, the kind who can independently lead R&D projects."

"However, his only request is to talk to you alone."

Zhang Yang was a little surprised when looking at the resume in front of him. Since the establishment of the "Drug Research and Development Center" of Qingshan Pharmaceutical, he rarely participated in the recruitment of researchers. It was almost always Wei Tian and Ren Xiaomin who were in charge of the review.

After he picked up the resume from the desk and read two pages carefully, he understood why Ren Xiaomin handed the resume to him personally.

"Fang Hanliang, 41 years old, holds a PhD in Biology from the University of Cambridge in the UK. He currently works for Boehringer Ingelheim, a top German biopharmaceutical company, or BI for short."

“Work experience: Participated in the research and development of the company’s main chronic kidney disease treatment drug ‘Empagliflozin’. Currently mainly responsible for the comprehensive research and development of another kidney disease drug code-named ‘BI-690517’ under BI.”

Boehringer Ingelheim is a Fortune 500 company and one of the world's top kidney disease drug research and development companies. Being able to lead the comprehensive research and development of a new drug in such a company is enough to prove Fang Hanliang's ability.

Just as Ren Xiaomin said, this is an industry expert who can already lead his own projects.

After thinking for two seconds, Zhang Yang nodded.

After all, although Qingshan Pharmaceutical's "Drug Research and Development Center" has been recruiting people continuously since its establishment, it is difficult to find top talents like Fang Hanliang.

After getting Zhang Yang's confirmation, Ren Xiaomin immediately started to make arrangements and the meeting time was set for the next afternoon.

Time passed in the blink of an eye and it was the next afternoon. Zhang Yang received Fang Hanliang very formally in his office.

The aroma of tea filled the air as the two men sat opposite each other on the sofa. Zhang Yang gave Fang Hanliang enough respect.

"Dr. Fang, I heard that you took the initiative to ask to talk to me. Now that we're meeting, what do you want to talk about?"

Zhang Yang spoke first. He did not act as superior as a boss, but chatted casually like a friend.

Fang Hanliang was also quite surprised by Zhang Yang's youth. He knew that Zhang Yang was not very old, but he didn't expect him to be so young.

But he quickly adjusted himself, pushed his glasses, and showed a hint of apology on his face:
"Mr. Zhang, I'm sorry to have wasted your time, but job hopping is a very important event in my life, so I have to be cautious."

Zhang Yang nodded slightly, signaling Fang Hanliang to continue. Seeing this, Fang Hanliang's expression also relaxed, and continued:
"To be honest, I have been planning to return to China in the past two years. One reason is that my father has liver cirrhosis and he wants me to return to China to be with him. I also have this idea."

"Secondly, the 'hepatocyte activator' developed by your company and the previous series of achievements are indeed impressive. As an insider in the pharmaceutical industry, I am very aware of the greatness of these drugs."

“So, I am relieved and am willing to try to join your company. But before that, I would like to ask you a question... Does the company currently plan to invest in the research and development of kidney drugs?

If so, could you tell me how much it costs? "

After the words were spoken, Zhang Yang was quite surprised by the sincerity of the words.

He didn't expect that Fang Hanliang neither took the initiative to talk about his past nor his position in the industry, but instead raised his questions sincerely.

Zhang Yang could fully understand this problem.

Simply put, after hundreds of years of development of human biopharmaceuticals, the entire pharmaceutical industry has entered the segmented market, and the vast majority of companies have been developing drugs only for certain diseases for one hundred or two hundred years.

For example, Gilead mainly studies liver disease and AIDS.

Therefore, Gilead has attracted countless drug developers with experience in the field of liver disease, or in other words, the best developers in the field of liver disease are in Gilead.

After all, the company's main business is liver disease, and it is willing to invest. Coupled with a large group of colleagues who also have strong capabilities in the field of liver disease, the probability of producing results is greatly increased.

Is it appropriate for a PhD in pharmacology who specializes in other areas, such as nephrology, to join Gilead?

Obviously not appropriate.

Tsingshan Pharmaceutical previously had some achievements mainly in the fields of blood diseases and liver diseases. As a researcher in the field of kidney disease, it is normal for Fang Hanliang to be worried about this.

After a moment, Zhang Yang said:

"I completely understand your concerns. Let me answer your first question first."

"To be honest, we not only intend to develop kidney disease drugs, but we have also achieved certain results in kidney disease drugs."

Fang Hanliang was stunned:
"You...you have achieved certain results in kidney disease drugs?"

Zhang Yang did not hide it and nodded:
"Due to the company's commercial confidentiality, I cannot reveal too many details to you, but I can tell you that this is a 'toxin metabolism needle' that is mainly used for dialysis patients and can temporarily replace dialysis."

"Its emergence is very likely to greatly improve the quality of life of dialysis patients."

Zhang Yang paused as he spoke:

"Now to answer your second question, our current R&D funding for the initial project is 5 million yuan. If there are subsequent R&D results, this investment can be expanded to 10 billion or even billion yuan."

Fang Hanliang was extremely shocked. He had never expected that Qingshan Pharmaceutical had already started research and development of kidney drugs, and had achieved certain results!

After a minute, he took a deep breath and nodded:

"Mr. Zhang, I understand. Thank you."

"I don't have a problem anymore."

This time it was Zhang Yang who was stunned.

"You're not going to talk about salary or benefits anymore?"

"no need."

Fang Hanliang smiled and shook his head.

"I have already seen the salary package you offer, and I am satisfied with it, so there is no need to discuss this matter any further."

As he spoke, Fang Hanliang stood up from the sofa:
"Okay, Mr. Zhang, I won't bother you any more, but I hope you can give me two days to think it over."

"Also, I am still an employee of BI Company. It will take me about half a year to process my resignation. I hope you can understand."

"Okay! I look forward to having you join me."

The meeting between the two was not too long, and this sincere way of communication also left Zhang Yang with a good impression of Fang Hanliang.

While Zhang Yang was dealing with the meeting with Fang Hanliang, on the other side, West China Dean Gan Weiguo was staring at an electronic invitation letter on the computer screen in a daze.

This is an invitation letter from the International Society of Nephrology (ISN), inviting West China Hospital to participate in the "Global Nephrology Summit" to be held in Shanghai this year.

The "Global Nephrology Summit" is held every two years and will invite doctors from the world's top kidney hospitals and major kidney disease drug research and development pharmaceutical companies to participate, aiming to exchange and learn the world's latest cutting-edge kidney disease technologies and drugs.

Every year, the Hua Xia region has two participating places. Since West China achieved breakthrough results in "kidney transplant matching" last year, this time it surpassed Southern Medical University and made it onto the invitation list.

At the same time, because of the breakthrough results achieved last year, West China also obtained a recommendation spot this time and can recommend a pharmaceutical company to participate in this summit.

For pharmaceutical companies, this is naturally a very good place to promote their own kidney disease drugs. However, after thinking it over, Gan Weiguo did not think of a suitable kidney disease manufacturer quickly.

His thoughts fell on Qingshan Pharmaceutical.

Ever since the last time Deputy Director Chen Yifei of the Hepatology Department jumped to Chengdu Third People's Hospital, Gan Weiguo realized that he had to establish a good relationship with Qingshan Pharmaceutical.

But after all the efforts, the results were not very good, and the relationship with Tsingshan Pharmaceutical was still lukewarm.

This precious summit spot is a good way to go, but...

Gan Weiguo was also somewhat undecided:
"Qingshan Pharmaceutical mainly has research and development results in liver and blood diseases, but has no outstanding achievements in the field of kidney disease. Is it appropriate to give Zhang Yang a spot in this kidney disease summit?"

"Besides, will it cause him to misunderstand or become dissatisfied? After all, they have not achieved any results in the field of kidney disease."

After hesitating for half an hour, Gan Weiguo decided to visit Zhang Yang in person to find out what Zhang Yang had to say.

If Qingshan Pharmaceutical is interested, I will give it the position. If they are not interested, I will just use it as a way to get closer to Zhang Yang.

Ten minutes later, under the watchful eyes of the security guards, he drove slowly away from West China and arrived at Qingshan Pharmaceutical.

The team leader Lao Luo was on duty today. When he saw a car with an unfamiliar license plate parked in front of the access control at the gate of Qingshan Pharmaceutical, he held the registration form in one hand and gently knocked on the car window with the other.

"Master, please register. Who are you looking for?"

Gan Weiguo glanced at Lao Luo, then said slowly:
"I am Gan Weiguo, the president of West China Hospital, and I am here to visit your President Zhang Yang."

Lao Luo was stunned for a moment, and even his words became stuttering.

"You...you are Dean Huaxi?!"

"Are you here to visit our CEO Zhang?"

……

PS: Thank you for the 100-coin reward from Smile Face the Wind

Thanks to Wanxing Mingxin for the 500-coin reward

Thanks to Ma Jiahezi for the reward of 5000 coins!
I was busy today and couldn't write anything. I will continue to update from tomorrow!
(End of this chapter)